Integrated multicenter deep learning system for prognostic prediction in bladder cancer

Precise survival risk stratification is crucial for personalized therapy in bladder cancer (BCa). This study developed and validated an end-to-end deep learning system using histological slides to predict overall survival (OS) risk in BCa patients. We employed the BlaPaSeg tile classifier to generate tissue probability heatmaps and segmentation maps, trained two prognostic networks, MacroVisionNet and UniVisionNet, and explored six potential BCa prognostic biomarkers. Across all cohorts, the AUC for BlaPaSeg ranged from 0.9906 to 0.9945, while the C-index varied from 0.655 to 0.834 for MacroVisionNet and 0.661 to 0.853 for UniVisionNet. After covariate adjustment, the hazard ratio (HR) values for high-risk groups were 1.97 to 5.06 in MacroVisionNet and 2.13 to 4.01 in UniVisionNet. The high-risk Coloc (Tumor Co-localization score) and IMTS (Integrated Muscle Tumor Score) groups illustrated a higher death risk with HR values from 1.41 to 10.16. The system improves BCa survival prediction and supports refined patient management.

Authors

Institutions

Publication Details

Journal
npj Precision Oncology
Published
2024-10-16
DOI
https://doi.org/10.1038/s41698-024-00731-6
Citations
10
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
5.73

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrated multicenter deep learning system for prognostic prediction in bladder cancer

Youde Cao, Hao Yang Tan, Mingzhao Xiao, Yiwen Tan et al.
10 citations
npj Precision Oncology
Bladder and Urothelial Cancer Treatments
5.73
article

Integrated multicenter deep learning system for prognostic prediction in bladder cancer

Youde Cao, Hao Yang Tan, Mingzhao Xiao, Yiwen Tan, Bing Liang, Cheng Wang, Bangxin Xiao, Quanhao He, Canjie Peng
article en
10 citations

Abstract

Precise survival risk stratification is crucial for personalized therapy in bladder cancer (BCa). This study developed and validated an end-to-end deep learning system using histological slides to predict overall survival (OS) risk in BCa patients. We employed the BlaPaSeg tile classifier to generate tissue probability heatmaps and segmentation maps, trained two prognostic networks, MacroVisionNet and UniVisionNet, and explored six potential BCa prognostic biomarkers. Across all cohorts, the AUC for BlaPaSeg ranged from 0.9906 to 0.9945, while the C-index varied from 0.655 to 0.834 for MacroVisionNet and 0.661 to 0.853 for UniVisionNet. After covariate adjustment, the hazard ratio (HR) values for high-risk groups were 1.97 to 5.06 in MacroVisionNet and 2.13 to 4.01 in UniVisionNet. The high-risk Coloc (Tumor Co-localization score) and IMTS (Integrated Muscle Tumor Score) groups illustrated a higher death risk with HR values from 1.41 to 10.16. The system improves BCa survival prediction and supports refined patient management.

npj Precision OncologyVol. 8(1)
Dalian Medical University (CN), Second Affiliated Hospital of Chongqing Medical University (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), Chongqing Medical University (CN)
Chongqing Medical University, Natural Science Foundation of Chongqing, Chongqing Municipal Education Commission, Centre Scientifique et Technique du Bâtiment
Openalex Percentile: Top 3%
Bladder and Urothelial Cancer Treatments
5.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Integrated multicenter deep learning system for prognostic prediction in bladder cancer — Youde Cao, Hao Yang Tan, et al. · npj Precision Oncology (2024) | TGRS Research Map | TGRS